Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer
The predictive value of anti-α3Gal IgE using these two assays was excellent and useful in clinical practice.
Authors
- Hervé Watier (ORCID: https://orcid.org/0000-0002-2139-4171)
- G. Calais
- Y. Pointreau (ORCID: https://orcid.org/0000-0002-2442-2879)
- Théodora Bejan‐Angoulvant (ORCID: https://orcid.org/0000-0002-0018-9996)
- David Ternant (ORCID: https://orcid.org/0000-0003-4020-4545)
- C Freneaux
Institutions
- Université de Tours (FR)
- Centre Hospitalier Universitaire de Tours (FR)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.iotech.2025.101041
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche